The development of drug metabolism research as expressed in the publications of ASPET: Part 1, 1909-1958

Drug Metabolism and Disposition

Volumn 36, Issue 1, 2008, Pages 1-5

  Murphy, Patrick J ^a,b  

^a BUTLER UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETANILIDE; ANALGESIC AGENT; ANTIINFECTIVE AGENT; ARSPHENAMINE; BARBITURIC ACID DERIVATIVE; DRUG METABOLITE; HEXOBARBITAL; MEPACRINE; MORPHINE; OXOPHENARSINE; PARACETAMOL; PETHIDINE; PRODRUG; SULFAMIDOCHRYSOIDINE; SULFANILAMIDE; TRYPANOTHIONE; XENOBIOTIC AGENT;

AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ANTIBACTERIAL ACTIVITY; DRUG ABSORPTION; DRUG ACETYLATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXPOSURE; DRUG FORMULATION; DRUG GLUCURONIDATION; DRUG MECHANISM; DRUG METABOLISM; DRUG RESEARCH; DRUG SULFATION; ELIXIR; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALARIA; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PUBLISHING; REDUCTION; SHORT SURVEY; SPIROCHETE; SYPHILIS; TRYPANOSOMA; UNSPECIFIED SIDE EFFECT;

BIOMEDICAL RESEARCH; HISTORY, 20TH CENTURY; PHARMACEUTICAL PREPARATIONS; SERIAL PUBLICATIONS; SOCIETIES, PHARMACEUTICAL; UNITED STATES;

EID: 37549047119     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.017079     Document Type: Short Survey

References (68)

1. Abel JJ and Rowntree LG (1909) On the pharmacological action of some phthaleins and their derivatives, with especial reference to their behavior as purgatives. J Pharmacol Exp Ther 1:231-264.
2. Adler TK and Shaw FH (1952) The biological liberation of morphine from codeine in the rat. J Pharmacol Exp Ther 104:1-10.
3. Axelrod J (1954) Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine. J Pharmacol Exp Ther 110:315-326.
4. Axelrod J (1955a) The enzymatic conversion of codeine to morphine. J Pharmacol Exp Ther 115:259-267.
5. Axelrod J (1955b) The enzymatic demethylation of ephedrine. J Pharmacol Exp Ther 114:430-438.
6. Axelrod J, Reichenthal J, and Brodie BB (1954) Mechanism of the potentiating action of β-diethylaminoethyldiphenylpropylacetate. J Pharmacol Exp Ther 112:49-54.
7. Bachmann C and Bickel MH (1985) History of drug metabolism: the first half of the 20th Century. Drug Metab Rev 16:185-253.
8. Bernheim F (1941) The reduction of neoprontosil by tissues in vitro. J Pharmacol Exp Ther 71:344-348.
9. Bernheim F and Bernheim M (1944) The oxidation in vitro of morphine by rat liver slices. J Pharmacol Exp Ther 81:374-377.
10. Bernheim F and Bernheim MLC (1945a) Note on the in vitro inactivation of morphine by liver. J Pharmacol Exp Ther 83:85.
11. Bernheim F and Bernheim MLC (1945b) The hydrolysis of demerol by liver in vitro. J Pharmacol Exp Ther 85:74-77.
12. Bernheim F and Bernheim MLC (1943) The conjugation in vitro of phenol by guinea pig liver. J Pharmacol Exp Ther 78:394-399.
13. Bickel MH (1996) Eli K. Marshall, Jr. (1889 -1966): from biochemistry and physiology to pharmacology and pharmacokinetics. Drug Metab Rev 28:311-344.
14. Bratton AC and Marshall EKJ (1939) A new coupling component for sulfanilamide determination. J Biol Chem 128:537-550.
15. Brodie BB and Axelrod J (1948a) The estimation of acetanilide and its metabolic products, aniline, N-acetylp-aminophenol and p-aminophenol (free and total conjugated) in biological fluids and tissues. J Pharmacol Exp Ther 94:22-28.
16. Brodie BB and Axelrod J (1948b) The fate of acetanilide in man. J Pharmacol Exp Ther 94:29-38.
17. Brodie BB, Axelrod J, Cooper JR, Gaudette L, La Du B, Mitoma C, and Udenfriend S (1955) Detoxication of drugs and other foreign compounds by liver microsomes. Science 121:603-604.
18. Brodie BB, Udenfriend S, and Baer JE (1947) The estimation of basic organic compounds in biological material. I. General principles. J Biol Chem 168:299-309.
19. Brodie BB and Udenfriend S, with the assistance of Baer JE, Chenkin T, and Dill W (1945) The estimation of basic organic compounds and a technique for the appraisal of specificity, application to the cinchona alkaloids. J Biol Chem 158:705-714.
20. Butler T (1956) The metabolic hydroxylation of phenobarbital. J Pharmacol Exp Ther 116:326-336.
21. Butler T (1971) Some historical reflections on drug metabolism. Ann N Y Acad Sci 179:502-507.
22. Butler TC (1948) The metabolic fate of chloral hydrate. J Pharmacol Exp Ther 92:49-58.
23. Butler TC (1953) Quantitative studies of the demethylation of trimethadione (tridione). J Pharmacol Exp Ther 108:11-17.
24. Butler TC (1957) The metabolic conversion of 5,5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin. J Pharmacol Exp Ther 119:1-11.
25. Butler TC, Mahaffee C, and Waddell WJ (1954) Phenobarbital: studies of elimination, accumulation, tolerance, and dosage schedules. J Pharmacol Exp Ther 111:425-435.
26. Chen K, ed (1969) The American Society for Pharmacology and Experimental Therapeutics, Incorporated: The First Sixty Years, 1908-1969, Judd & Detweiler, Washington, DC.
27. Colebrook L and Kenny M (1936) Treatment with prontosil of puerperal infections due to hemolytic streptococci. Lancet 2:1319 -1322.
28. Conti A and Bickel MH (1977) History of drug metabolism. Discoveries of the major pathways in the 19th century. Drug Metab Rev 6:1-50.
29. Cook L, Macko E, and Fellows EJ (1954a) The effect of β-diethylaminoethyldiphenylpropylacetate hydrochloride on the action of a series of barbiturates and C.N.S. depressants. J Pharmacol Exp Ther 112:382-386.
30. Cook L, Toner JJ, and Fellows EJ (1954b) The effect of β-diethylaminoethyldiphenylpropylacetate hydrochloride (SKF No. 525a) on hexobarbital. J Pharmacol Exp Ther 111:131-141.
31. Cooper JR, Axelrod J, and Brodie BB (1954) Inhibitory effects of β-diethylaminoethyldiphenylpropylacetate on a variety of drug metabolic pathways in vitro. J Pharmacol Exp Ther 112:55-63.
32. Cooper JR and Brodie BB (1955) The enzymatic metabolism of hexobarbital (evipal). J Pharmacol Exp Ther 114:409-417.
33. Costa E, Karczmar AG, and Vesell ES (1989) Bernard B. Brodie and the rise of chemical pharmacology. Annu Rev Pharmacol Toxicol 29:1-22.
34. Craig LC (1944) Identification of small amounts of organic compounds by distribution studies. II. Separation by counter-current distribution. J Biol Chem 155:519-534.
35. Ehrlich P and Hata S (1911) The Experimental Chemotherapy of Spirillosis, Rebman Company, New York.
36. Elliott HW, Chang FNH, Abdou IA, and Anderson HH (1949) The distribution of radioactivity in rats after administration of C14-labeled methadone. J Pharmacol Exp Ther 95:494-501.
37. Estabrook RW (2003) A tribute to James Robert Gillette. Drug Metab Dispos 31:1459-1460.
38. Fairlamb AH, Blackburn P, Ulrich P, Chait BT, and Cerami A (1985) Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 227:1485-1487.
39. Garfinkel D (1958) Studies on pig liver microsomes. I. Enzymic and pigment composition of different microsomal fractions. Arch Biochem Biophys 77:493-509.
40. Gillette JH, Brodie BB, and La Du BN (1957) The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. J Pharmacol Exp Ther 119:532-540.
41. Greenberg LA and Lester D (1946) The metabolic fate of acetanilid and other aniline derivatives: I. Major metabolites of acetanilid appearing in the urine. J Pharmacol Exp Ther 88:87-98.
42. Hager T (2006) The Demon Under the Microscope, Harmony Books, New York.
43. Hatcher RA and Eggleston C (1917) The fate of strychnin in the body. J Pharmacol Exp Ther 10:281-319.
44. Kato R and Yamazoe Y (2000) History of drug metabolism research in Japan. Drug Metab Rev 32:45-79.
45. Klingenberg M (1958) Pigments of rat liver microsomes. Arch Biochem Biophys 75:376-386.
46. Latham ME and Elliott HW (1951) Some aspects of the metabolism of codeine in the rat. J Pharmacol Exp Ther 101:259-267.
47. Lester D, Greenberg LA, and Carroll RP (1947) The metabolic fate of acetanilid and other aniline derivatives: II. Major metabolites of acetanilid appearing in the blood. J Pharmacol Exp Ther 90:68-75.
48. Lloyd NC, Morgan HW, Nicholson BK, and Ronimux RS (2005) The composition of Ehrlich's salvarsan: resolution of a century-old debate. Angew Chem Int Ed Engl 44:941-944.
49. Mannering GJ (2001) A life in science: biochemist-nutritionist-forensic toxicologist-pharmacologist. Drug Metab Rev 33:81-116.
50. Mannering GJ, Dixon AC, Baker EMI, and Asami T (1954) The in vivo liberation of morphine form codeine in man. J Pharmacol Exp Ther 111:142-146.
51. Marshall EKJ, Emerson KJ, and Cutting WC (1937) The distribution of sulfanilamide in the organism. J Pharmacol Exp Ther 61:196-204.
52. Maynert EW and Dyke HB (1949) The metabolism of barbiturates. Pharmacol Rev 1:217-242.
53. Michel HO, Bernheim F, and Bernheim MLC (1937) The hydrolysis of acetanilide by various tissues. J Pharmacol Exp Ther 61:321-327.
54. Morris HJ, Nelson AA, and Calvrey HO (1942) Observations on the chronic toxicities of propylene glycol, ethylene glycol, diethylene glycol, ethylene glycol mono-ethyl-ether, and diethylene glycol mono-ethyl-ether. J Pharmacol Exp Ther 74:266-273.
55. Murphy PJ (2001) Xenobiotic metabolism: a look from the past to the future. Drug Metab Dispos 29:779-780.
56. Oberst FW (1941) Relationship of the chemical structure of morphine derivatives to their urinary excretion in free and bound forms. J Pharmacol Exp Ther 73:401-404.
57. Parascandola J (1992) The Development of American Pharmacology, p. 44, The Johns Hopkins University Press, Baltimore.
58. Parke D (1997) A history of drug metabolism in the United Kingdom. Drug Metab Rev 29:801-851.
59. Schmidt LH, Hughes HB, and Smith CC (1947) On the pharmacology of N1-para-chlorophenyl-N5-isopropylbiguanide (paludrine). J Pharmacol Exp Ther 90:233-253.
60. Shannon JA, Earle DPJ, Brodie BB, Taggart JV, Berliner RW, and staff residents (1944) The pharmacological basis for the rational use of atabrine in the treatment of malaria. J Pharmacol Exp Ther 81:307-330.
61. Smith CC (1956) Metabolism of pentaquine in the Rhesus monkey. J Pharmacol Exp Ther 116:67-76.
62. Sollmann T, Hanzlik PJ, and Pilcher JD (1910) Quantitative studies on the gastrointestinal absorption of drugs I. The inhibitory action of phenol on absorption. J Pharmacol Exp Ther 1:409-444.
63. Stitzel R (1999) Editor's note: Pharmacological Reviews in review. Pharmacol Rev 51:1-6.
64. Swinyard EA, Madsen JA, and Goodman LS (1954) The effect of β-diethylaminoethyldiphenylpropylacetate (SKF No. 525a) on the anticonvulsant properties of antiepileptic drugs. J Pharmacol Exp Ther 111:54-63.
65. Trefouél J, Trefouél J, Nitti F, and Bovet D (1935) Activity of p-aminophenylsulfamide in the experimental streptococcal infections of the mouse and rabbit. C R Seances Soc Biol 120:756.
66. Voegtlin C, Dyer HA, and Leonard CS (1925) On the specificity of the so-called arsenic receptor in the higher animals. J Pharmacol Exp Ther 25:297-307.
67. Voegtlin C and Smith HW (1920) Quantitative studies in chemotherapy III. The oxidation of arsphenamine. J Pharmacol Exp Ther 16:199-217.
68. Williams RT (1959) Detoxication Mechanisms, John Wiley & Sons, Inc., New York.